Keywords: داروی ضد تشنج; Hippocampus; Cytokines; Inflammation; Epilepsy; Activated microglia; ASD; Anti-Seizure Drug; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ATP; Adenosine Triphosphate; DAMP; Danger Associated Molecular Pattern; FS; Febrile Seizures; GABA; G
مقالات ISI داروی ضد تشنج (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: داروی ضد تشنج; AE; adverse event; ANT; anterior nucleus of the thalamus; ASD; anti-seizure drug; BVMT-R; Brief Visual Memory Test-Revised; CVLT; California Verbal Learning Test; DBS; deep brain stimulation; D-KEFS; Delis-Kaplan Executive Function System; EEG; electroe
Keywords: داروی ضد تشنج; AES; American Epilepsy Society; ASD; anti-seizure drug; ASP; Anticonvulsant Screening Program; BLA; basolateral amygdala; CC; convulsant current; CD; convulsive dose; BBB; blood-brain barrier; CNS; central nervous system; ED; effective dose; ETSP; Epileps
Keywords: داروی ضد تشنج; Nonadherence; Epilepsy; Drug discovery; Noncompliance; Anti-seizure drug; Chronic drug delivery;
Evaluation of perampanel as monotherapy for focal seizures: Experience from open-label extension studies
Keywords: داروی ضد تشنج; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; bid; twice daily; FDA; Food and Drug Administration; OLEx; open-label extension; qam; every morning; qd; once daily; qhs; every night at bedtime; qpm; every evening; SG; secondarily generalized;
Methylated flavonoids as anti-seizure agents: Naringenin 4â²,7-dimethyl ether attenuates epileptic seizures in zebrafish and mouse models
Keywords: داروی ضد تشنج; Epilepsy; Drug discovery; Methylated flavonoids; Naringenin; Zebrafish; Mouse; AED; anti-epileptogenic drug; ASD; anti-seizure drug; cLogP; calculated LogP; dpf; days post-fertilization; DMSO; dimethyl sulfoxide; GABA; γ-aminobutyric acid; IL-1β; interl
The novel, catalytic mTORC1/2 inhibitor PQR620 and the PI3K/mTORC1/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy
Keywords: داروی ضد تشنج; Epilepsy; Rapamycin; Everolimus; Pharmacokinetics; Tolerability; Levetiracetam; AKT; protein kinase B; ASD; anti-seizure drug; 4E-BP1; initiation factor 4E binding protein; HPβCD; hydroxypropyl-Ã-cyclodextrin; MTD; maximal tolerated dose; MES-T; maximal
Clinical utility of EEG in diagnosing and monitoring epilepsy in adults
Keywords: داروی ضد تشنج; aEEG; ambulatory electroencephalography; ACNS; American Clinical Neurophysiology Society; ASD; anti-seizure drug; CAA-EEG; computer-assisted aEEG; cEEG; continuous electroencephalography; ECG; electrocardiogram; ECS; electrical cortical stimulation; ECoG;
Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy
Keywords: داروی ضد تشنج; Epilepsy; Anti-seizure drugs; Neonatal seizures; GABA; Giant depolarizing potentials; ADT; afterdischarge threshold; ASD; anti-seizure drug; BBB; blood-brain barrier; BMP; bumepamine; CCC; cation-chloride cotransporter; CNS; central nervous sytem; CSF;
Clinical development of drugs for epilepsy: A review of approaches in the United States and Europe
Keywords: داروی ضد تشنج; Epilepsy; Seizure; Antiepileptic drug; Anti-seizure drug; Drug development; FDA; EMEA; Regulation; Drug registration